PULMONARY THROMBOEMBOLISM FOLLOWING RADIO-FREQUENCY ABLATION OF THE ATRIOVENTRICULAR NODE IN A PATIENT HETEROZYGOUS FOR THE FACTOR V LEIDEN AND THE MTHFR C677T MUTATIONS

被引:3
|
作者
Pesut, D. P. [1 ]
Raljevic, S., V [2 ]
Kontic, M. Dj [2 ]
Bozic, D. Z. [2 ]
Buha, I. B. [2 ]
Stevic, R. S. [1 ,3 ]
机构
[1] Univ Belgrade, Sch Med, Dept Internal Med, Belgrade 11001, Serbia
[2] Teaching Hosp Lung Dis, Clin Ctr Serbia, Res & Epidemiol Dept, Belgrade, Serbia
[3] Ctr Radiol & Magnet Resonance, Clin Ctr Serbia, Belgrade, Serbia
关键词
Thromboembolism; Radiofrequency ablation; Atrioventricular (AV) node; Factor V (FV) Leiden mutation; Risk factor; ACTIVATED PROTEIN-C; PROTHROMBIN G20210A; VENOUS THROMBOSIS; ATRIAL-FIBRILLATION; CATHETER ABLATION; VEIN-THROMBOSIS; RISK; THROMBOPHILIA; TACHYCARDIA; PREVALENCE;
D O I
10.2478/v10034-011-0018-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Patients who undergo radiofrequency ablation of the atrioventricular (AV) node rarely develop acute major complications. A 41-year-old Caucasian male smoker, was admitted to the Pulmology Teaching Hospital at Belgrade, Serbia, for sharp persistent chest pain, fever and fatigue following AV node radiofrequency ablation for arrhythmia. Chest X-ray showed obtuse right costo-phrenic angle and laminar atelectasis in the right lower lung lobe. The plasma D-dimer level was elevated. A perfusion lung scan showed multiple bilateral perfusion defects and multislice computed tomography showed thrombotic mass in the right pulmonary artery. Genetic analysis revealed that he was heterozygous for the prothrombin Factor V (FV) Leiden and MTHFR C677T mutations. Therapy started with intravenous heparin, followed by warfarin. He had no other episodes over a 2-year follow-up. Lifelong oral anticoagulant therapy was recommended.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 50 条
  • [1] Glanzmann Thrombasthenia in a Newborn with Heterozygous Factor V Leiden and Heterozygous MTHFR C677T Gene Mutations
    Gultekin, Nazli Dilay
    Yilmaz, Fatma Hilal
    Tokgoz, Huseyin
    Tarakci, Nuriye
    Caliskan, Umran
    INDIAN PEDIATRICS, 2019, 56 (02) : 143 - 144
  • [2] Glanzmann Thrombasthenia in a Newborn with Heterozygous Factor V Leiden and Heterozygous MTHFR C677T Gene Mutations
    Nazli Dilay Gultekin
    Fatma Hilal Yilmaz
    Huseyin Tokgoz
    Nuriye Tarakci
    Umran Caliskan
    Indian Pediatrics, 2019, 56 : 143 - 144
  • [3] Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians
    Vanegas, OC
    Giusti, B
    Fernandez, CMR
    Abbate, R
    Pepe, G
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (04) : 883 - 884
  • [4] Renal transplantation experience in a patient with factor V Leiden homozygous, MTHFR C677T heterozygous, and PAI heterozygous mutation
    Gulhan, Bora
    Tavil, Betul
    Gumruk, Fatma
    Aki, Tuncay F.
    Topaloglu, Rezan
    PEDIATRIC TRANSPLANTATION, 2015, 19 (05) : E126 - E129
  • [5] Pulmonary Thromboembolism Diagnosed by Transthoracic Echocardiography in an Ulcerative Colitis Patient with Compound Heterozygous MTHFR C677T/MTHFR A1298C Mutations
    Yenercag, M.
    Yuksel, S.
    Gulel, O.
    Sahin, M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (07): : S145 - S145
  • [6] Factor V Leiden, prothrombin 20210 G → A and the MTHFR C677T mutations in childhood stroke
    McColl, MD
    Chalmers, EA
    Thomas, A
    Sproul, A
    Healey, C
    Rafferty, I
    McWilliam, R
    Eunson, P
    THROMBOSIS AND HAEMOSTASIS, 1999, 81 (05) : 690 - 694
  • [7] Distribution of Factor V Leiden, Prothrombin G20210A and MTHFR C677T mutations in Georgian population
    Pirtskhelani, N.
    Kochiashvili, N.
    Kartvelishvili, K.
    Makhaldiani, L.
    Pargalava, N.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 1007 - 1008
  • [8] Papillophlebitis Associated With Coexisting Heterozygous Mutations of Factor V Leiden and Methylenetetrahydrofolate Reductase Enzyme-(C677T)
    Ntora, Efthalia
    Dalianis, Georgios
    Terzidou, Chryssa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [9] Prevalence of factor V Leiden and methylenetetrahydrofolate reductase C677T mutations in Azerbaijan
    Gurgey, A
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (03) : 520 - 521
  • [10] Prevalence of the factor V Leiden mutation and the MTHFR C677T mutation in thrombophilic and in healthy persons
    Gaustadnes, M
    Larsen, TB
    Ingerslev, J
    Petersen, BN
    Madsen, M
    Bihl, K
    Rudiger, N
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2324 - P2324